Clinical Trials Browser

Phase 1/2 × FED × Has results × Clear all

NCT04037462 2024-06-14

Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy

Phase 1/2 Terminated

2 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Phase 1/2 Completed

21 enrolled 10 charts

Mouth Neoplasms

NCT01324102 2016-01-01

YogaCares

Phase 1/2 Completed

23 enrolled 6 charts

Neoplasms